-
Je něco špatně v tomto záznamu ?
Je časné zahájení dialyzační léčby u nemocných s CKD výhodné? Studie IDEAL
[Randomized, controlled trial of early versus late initiation of dialysis]
Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA
Jazyk čeština Země Česko
Typ dokumentu multicentrická studie
- MeSH
- časové faktory MeSH
- chronické selhání ledvin komplikace mortalita terapie MeSH
- dialýza ledvin metody škodlivé účinky MeSH
- dospělí MeSH
- financování organizované MeSH
- hodnoty glomerulární filtrace MeSH
- infekce etiologie mortalita MeSH
- Kaplanův-Meierův odhad MeSH
- kardiovaskulární nemoci etiologie mortalita MeSH
- kvalita života MeSH
- lidé středního věku MeSH
- lidé MeSH
- proporcionální rizikové modely MeSH
- randomizované kontrolované studie jako téma MeSH
- uremie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- multicentrická studie MeSH
In clinical practice, there is considerable variation in the timing of the initiation of maintenance dialysis for patients with stage V chronic kidney disease, with a worldwide trend toward early initiation. In this study, conducted at 32 centers in Australia and New Zealand, we examined whether the timing of the initiation of maintenance dialysis influenced survival among patients with chronic kidney disease. METHODS: We randomly assigned patients 18 years of age or older with progressive chronic kidney disease and an estimated glomerular filtration rate (GFR) between 10.0 and 15.0 ml per minute per 1.73 m2 of body-surface area (calculated with the use of the Cockcroft-Gault equation) to planned initiation of dialysis when the estimated GFR was 10.0 to 14.0 ml per minute (early start) or when the estimated GFR was 5.0 to 7.0 ml per minute (late start). The primary outcome was death from any cause. RESULTS: Between July 2000 and November 2008, a total of 828 adults (mean age, 60.4 years; 542 men and 286 women; 355 with diabetes) underwent randomization, with a median time to the initiation of dialysis of 1.80 months (95% confidence interval [CI], 1.60 to 2.23) in the early-start group and 7.40 months (95% CI, 6.23 to 8.27) in the late-start group. A total of 75.9% of the patients in the late-start group initiated dialysis when the estimated GFR was above the target of 7.0 ml per minute, owing to the development of symptoms. During a median follow-up period of 3.59 years, 152 of 404 patients in the early-start group (37.6%) and 155 of 424 in the late-start group (36.6%) died (hazard ratio with early initiation, 1.04; 95% CI, 0.83 to 1.30; P=0.75). There was no significant difference between the groups in the frequency of adverse events (cardiovascular events, infections, or complications of dialysis). CONCLUSIONS: In this study, planned early initiation of dialysis in patients with stage V chronic kidney disease was not associated with an improvement in survival or clinical outcomes. (Funded by the National Health and Medical Research Council of Australia and others; Australian New Zealand Clinical Trials Registry number, 12609000266268.)
Randomized, controlled trial of early versus late initiation of dialysis
Komentář [k článku Je časné zahájení dialyzační léčby u nemocných s CKD výhodné? Studie IDEAL].
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10028432
- 003
- CZ-PrNML
- 005
- 20111210192744.0
- 008
- 101025s2010 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Cooper, B. A.
- 245 10
- $a Je časné zahájení dialyzační léčby u nemocných s CKD výhodné? Studie IDEAL / $c Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA
- 246 11
- $a Randomized, controlled trial of early versus late initiation of dialysis
- 314 __
- $a Department of Renal Medicine, Royal North Shore Hospital, Sydney Medical School, Sydney bcooper@med.usyd.edu.au
- 520 9_
- $a In clinical practice, there is considerable variation in the timing of the initiation of maintenance dialysis for patients with stage V chronic kidney disease, with a worldwide trend toward early initiation. In this study, conducted at 32 centers in Australia and New Zealand, we examined whether the timing of the initiation of maintenance dialysis influenced survival among patients with chronic kidney disease. METHODS: We randomly assigned patients 18 years of age or older with progressive chronic kidney disease and an estimated glomerular filtration rate (GFR) between 10.0 and 15.0 ml per minute per 1.73 m2 of body-surface area (calculated with the use of the Cockcroft-Gault equation) to planned initiation of dialysis when the estimated GFR was 10.0 to 14.0 ml per minute (early start) or when the estimated GFR was 5.0 to 7.0 ml per minute (late start). The primary outcome was death from any cause. RESULTS: Between July 2000 and November 2008, a total of 828 adults (mean age, 60.4 years; 542 men and 286 women; 355 with diabetes) underwent randomization, with a median time to the initiation of dialysis of 1.80 months (95% confidence interval [CI], 1.60 to 2.23) in the early-start group and 7.40 months (95% CI, 6.23 to 8.27) in the late-start group. A total of 75.9% of the patients in the late-start group initiated dialysis when the estimated GFR was above the target of 7.0 ml per minute, owing to the development of symptoms. During a median follow-up period of 3.59 years, 152 of 404 patients in the early-start group (37.6%) and 155 of 424 in the late-start group (36.6%) died (hazard ratio with early initiation, 1.04; 95% CI, 0.83 to 1.30; P=0.75). There was no significant difference between the groups in the frequency of adverse events (cardiovascular events, infections, or complications of dialysis). CONCLUSIONS: In this study, planned early initiation of dialysis in patients with stage V chronic kidney disease was not associated with an improvement in survival or clinical outcomes. (Funded by the National Health and Medical Research Council of Australia and others; Australian New Zealand Clinical Trials Registry number, 12609000266268.)
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a kardiovaskulární nemoci $x etiologie $x mortalita $7 D002318
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hodnoty glomerulární filtrace $7 D005919
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a infekce $x etiologie $x mortalita $7 D007239
- 650 _2
- $a Kaplanův-Meierův odhad $7 D053208
- 650 _2
- $a chronické selhání ledvin $x komplikace $x mortalita $x terapie $7 D007676
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a proporcionální rizikové modely $7 D016016
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a dialýza ledvin $x metody $x škodlivé účinky $7 D006435
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a uremie $7 D014511
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Branley, P.
- 700 1_
- $a Bulfone, L.
- 700 1_
- $a Collins, J. F.
- 700 1_
- $a Craig, J. C.
- 700 1_
- $a Fraenkel, M. B.
- 700 1_
- $a Harris, A.
- 700 1_
- $a Johnson, D. W.
- 700 1_
- $a Kesselhut, J.
- 700 1_
- $a Li, J. J.
- 700 1_
- $a Luxton, G.
- 700 1_
- $a Pilmore, A.
- 700 1_
- $a Tiller, D. J.
- 700 1_
- $a Harris, D. C.
- 700 1_
- $a Pollock, C. A.
- 773 0_
- $w MED00012709 $t Postgraduální nefrologie $g Roč. 8, č. 4 (2010), s. 54-55 $x 1214-178X
- 787 18
- $w bmc10028433 $i Recenze v: $t Komentář [k článku Je časné zahájení dialyzační léčby u nemocných s CKD výhodné? Studie IDEAL]
- 856 41
- $u http://www.transplant.cz/vzdelavani/2010/10_04_07.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2318 $c 893 $y 7
- 990 __
- $a 20101013125906 $b ABA008
- 991 __
- $a 20110131102331 $b ABA008
- 999 __
- $a ok $b bmc $g 803546 $s 668319
- BAS __
- $a 3
- BMC __
- $a 2010 $b 8 $c 4 $d 54-55 $m Postgraduální nefrologie $x MED00012709
- LZP __
- $a 2010-29/mkme